The MORE Act was passed this past week and it was the first time that any cannabis bill addressing descheduling was approved by Congress. This bill will also change the tax code and allow companies to deduct certain expenses.
Here is a list of the cannabis stocks to watch and their performance from this past week by the percentage change at the close of trading on Dec. 11.
Aurora Cannabis Inc | Decreased -9.09% | Price $9.91
TheStreet Quant Ratings rates Aurora Cannabis Inc. as a Sell with a rating score of D-.
Arena Pharmaceuticals | Increased +3.19% | Price $69.91
TheStreet Quant Ratings rates Arena Pharmaceuticals as a Hold with a rating score of C.
Cronos Group Inc | Decreased -7.53% | Price $7.98
TheStreet Quant Ratings rates Cronos Group as a Sell with a rating score of D.
Tilray Inc | Decreased -9.65% | Price $7.77
TheStreet Quant Ratings rates Tilray as a Sell with a rating score of D.
Cara Therapeutics | Decreased -1.13% | Price $14.91
TheStreet Quant Ratings rates Cara Therapeutics as a Sell with a rating score of D.
Canopy Growth Corp | Decreased -7.21% | Price $26.53
TheStreet Quant Ratings rates Canopy Growth Corp as a Hold with a rating score of C.
GW Pharmaceuticals | Decreased -12.41% | Price $120.43
TheStreet Quant Ratings rates GW Pharma as a Sell with a rating score of D+.